Literature DB >> 22451603

Clinicopathological insights into lupus nephritis in South Africans: a study of 251 patients.

I G Okpechi1, C R Swanepoel, N Tiffin, M Duffield, B L Rayner.   

Abstract

There are few published studies on biopsy proven lupus nephritis (LN) from sub-Sahara Africa, mainly due to lack of expertise and pathology back-up for performing and interpreting renal biopsies in many centres. The purpose of this study was to document factors associated with biopsy proven LN and to determine clinical and laboratory models that best predict proliferative LN in South Africans. Of the 251 patients studied, 84.1% were females and 79.3% were of mixed ancestry. There were more observed cases of proliferative LN (63%) than non-proliferative LN. Factors associated with proliferative LN were male gender (p = 0.049), haematuria on dipstix (p < 0.0001), proteinuria on dipstix (p = 0.042), low serum albumin (p = 0.032), low complement C3 (p < 0.0001), low complement C4 (p = 0.009) and positive double-stranded DNA (p = 0.039). Using four models designed from various combinations of the factors associated with proliferative LN, the specificity and positive predictive values were highest for the model that combined gender (male), presence of dipstix haematuria and proteinuria, hypoalbuminaemia, low C3 and low C4 and positive double-stranded DNA (100% respectively). Further study is recommended to identify the value of using these demographic and laboratory parameters in identifying patients with proliferative LN in resource limited centres where the performance of a biopsy is not possible.

Entities:  

Mesh:

Year:  2012        PMID: 22451603     DOI: 10.1177/0961203312441981

Source DB:  PubMed          Journal:  Lupus        ISSN: 0961-2033            Impact factor:   2.911


  7 in total

Review 1.  Nephrology in Africa--not yet uhuru.

Authors:  Charles R Swanepoel; Nicola Wearne; Ikechi G Okpechi
Journal:  Nat Rev Nephrol       Date:  2013-08-20       Impact factor: 28.314

2.  Comparing the Efficacy and Safety of Induction Therapies for the Treatment of Patients with Proliferative Lupus Nephritis in South Africa.

Authors:  Phelisa Sogayise; Udeme Ekrikpo; Ayanda Gcelu; Bianca Davidson; Nicola Wearne; Ugochi Okpechi-Samuel; Theophilus Ifeanyichukwu Umeizudike; Innocent Ijezie Chukwuonye; Ikechi Okpechi
Journal:  Int J Nephrol       Date:  2020-10-19

3.  [Clinical profile and survival of patients with lupus nephritis in the department of nephrology in Cameroon: a single-center study].

Authors:  Hermine Danielle Fouda Menye Ebana; Maimouna Mahamat; Fernando Kemta Lekpa; Caroline Kenmegne Jemmy; Gloria Ashuntantang; Marie-Patrice Halle
Journal:  Pan Afr Med J       Date:  2022-03-14

4.  Clinicopathological correlation in asian patients with biopsy-proven lupus nephritis.

Authors:  Bancha Satirapoj; Pamila Tasanavipas; Ouppatham Supasyndh
Journal:  Int J Nephrol       Date:  2015-03-19

5.  Proliferative Glomerulonephritis: Risk Factor for Hypertension in Lupus.

Authors:  Mansour Mbengue; Motula Latou Lot; Seynabou Diagne; Abdou Niang
Journal:  Int J Hypertens       Date:  2021-04-15       Impact factor: 2.420

6.  Management practice and treatment outcomes of adult patients with Lupus Nephritis at the Renal Clinic of St. Paul's Hospital Millennium Medical College, Addis Ababa, Ethiopia.

Authors:  Gebre-Mariam Tsegay Hailu; Shemsu Umer Hussen; Seifemichael Getachew; Alemseged Beyene Berha
Journal:  BMC Nephrol       Date:  2022-06-17       Impact factor: 2.585

7.  Haematuria on the Spanish Registry of Glomerulonephritis.

Authors:  Claudia Yuste; Francisco Rivera; Juan Antonio Moreno; Juan Manuel López-Gómez
Journal:  Sci Rep       Date:  2016-01-28       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.